Quarterly ResultAug 3, 2026, 04:13 PM
Inspire Medical Q2 Revenue $200.6M, Net Earnings $0.3M
AI Summary
Inspire Medical Systems reported Q2 2026 revenue of $200.6 million, a decrease from $217.1 million in Q2 2025, but achieved net earnings of $0.3 million, a significant improvement from a net loss of $3.6 million in the prior year quarter. For the first six months of 2026, revenue was $405.2 million, down from $418.4 million, with a net loss of $11.0 million compared to a $0.6 million loss in the same period last year. The company generated $36.1 million in cash from operations for the six months ended June 30, 2026, a substantial increase from a cash outflow in the prior year. Additionally, a securities class action lawsuit was transferred to Minnesota and an amended complaint was filed.
Key Highlights
- Q2 2026 revenue was $200.6 million, down from $217.1 million in Q2 2025.
- Q2 2026 net earnings were $0.3 million, compared to a net loss of $3.6 million in Q2 2025.
- Six months 2026 net loss was $11.0 million, compared to a $0.6 million loss in six months 2025.
- Net cash provided by operating activities for six months 2026 was $36.1 million, up from $(4.0) million.
- International revenue for Q2 2026 increased to $13.3 million from $9.9 million in Q2 2025.
- US revenue for Q2 2026 decreased to $187.3 million from $207.2 million in Q2 2025.
- Unrecognized stock-based compensation expense totals $199.3 million over 2.1 years.
- Indiana Public Retirement System lawsuit transferred to Minnesota, amended complaint filed.
Price Impact
More from INSP